Canandaigua National Bank & Trust Co. reduced its position in Oracle Corporation (NYSE:ORCL – Free Report) by 3.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 73,695 shares of the enterprise software provider’s stock after selling 2,813 shares during the quarter. Oracle makes up 1.8% of Canandaigua National Bank & Trust Co.’s portfolio, making the stock its 10th largest holding. Canandaigua National Bank & Trust Co.’s holdings in Oracle were worth $20,726,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. Brighton Jones LLC boosted its position in shares of Oracle by 189.3% during the 4th quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider’s stock valued at $25,593,000 after acquiring an additional 100,494 shares in the last quarter. Revolve Wealth Partners LLC lifted its stake in Oracle by 8.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider’s stock worth $903,000 after purchasing an additional 404 shares during the period. Versor Investments LP acquired a new stake in Oracle during the first quarter valued at approximately $590,000. Venture Visionary Partners LLC grew its stake in shares of Oracle by 8.0% in the 1st quarter. Venture Visionary Partners LLC now owns 24,029 shares of the enterprise software provider’s stock valued at $3,360,000 after purchasing an additional 1,782 shares during the period. Finally, Humankind Investments LLC raised its holdings in shares of Oracle by 9.0% in the 1st quarter. Humankind Investments LLC now owns 1,532 shares of the enterprise software provider’s stock worth $214,000 after buying an additional 126 shares in the last quarter. Institutional investors and hedge funds own 42.44% of the company’s stock.
Analysts Set New Price Targets
Several analysts recently commented on ORCL shares. Barclays set a $310.00 price target on Oracle in a research note on Thursday, December 11th. TD Cowen cut their price objective on Oracle from $400.00 to $350.00 and set a “buy” rating for the company in a report on Thursday, December 11th. Jefferies Financial Group boosted their target price on shares of Oracle from $360.00 to $400.00 and gave the company a “buy” rating in a research note on Friday, October 17th. Bank of America dropped their target price on shares of Oracle from $368.00 to $300.00 and set a “buy” rating for the company in a research report on Thursday, December 11th. Finally, Erste Group Bank downgraded shares of Oracle from a “buy” rating to a “hold” rating in a report on Monday, November 10th. Three equities research analysts have rated the stock with a Strong Buy rating, twenty-seven have assigned a Buy rating, eleven have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $302.92.
Insider Activity
In other Oracle news, insider Michael D. Sicilia sold 33,845 shares of the stock in a transaction on Tuesday, September 23rd. The stock was sold at an average price of $321.16, for a total value of $10,869,660.20. Following the transaction, the insider directly owned 132,656 shares in the company, valued at approximately $42,603,800.96. This trade represents a 20.33% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Stuart Levey sold 19,758 shares of Oracle stock in a transaction on Friday, October 10th. The shares were sold at an average price of $300.00, for a total value of $5,927,400.00. Following the completion of the sale, the executive vice president directly owned 18,429 shares of the company’s stock, valued at $5,528,700. This trade represents a 51.74% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 155,190 shares of company stock worth $45,279,001. 40.90% of the stock is owned by company insiders.
Oracle Stock Down 5.4%
Shares of NYSE ORCL opened at $178.46 on Thursday. Oracle Corporation has a 12-month low of $118.86 and a 12-month high of $345.72. The firm’s 50-day simple moving average is $239.32 and its 200 day simple moving average is $241.81. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 3.28. The company has a market cap of $512.74 billion, a price-to-earnings ratio of 33.55, a price-to-earnings-growth ratio of 1.70 and a beta of 1.66.
Oracle (NYSE:ORCL – Get Free Report) last posted its quarterly earnings data on Wednesday, December 10th. The enterprise software provider reported $2.26 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.62. Oracle had a net margin of 25.28% and a return on equity of 70.60%. The firm had revenue of $16.06 billion during the quarter, compared to analysts’ expectations of $16.19 billion. During the same quarter last year, the company posted $1.47 EPS. The company’s quarterly revenue was up 14.2% compared to the same quarter last year. On average, research analysts expect that Oracle Corporation will post 5 earnings per share for the current fiscal year.
Oracle Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 23rd. Shareholders of record on Friday, January 9th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, January 9th. This represents a $2.00 annualized dividend and a yield of 1.1%. Oracle’s dividend payout ratio is currently 37.59%.
Oracle Profile
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
See Also
- Five stocks we like better than Oracle
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Post 35% Surge, Analysts Eye More Upside in Copper Giant Freeport
- Expert Stock Trading Psychology Tips
- Why a SpaceX IPO Could Be a Major Catalyst for GOOGL Stock
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
